167 related articles for article (PubMed ID: 34244019)
1. Cerebral involvement and related aspects in myotonic dystrophy type 2.
Peric S; Rakocevic-Stojanovic V; Meola G
Neuromuscul Disord; 2021 Aug; 31(8):681-694. PubMed ID: 34244019
[TBL] [Abstract][Full Text] [Related]
2. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
3. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.
Romeo V; Pegoraro E; Ferrati C; Squarzanti F; Sorarù G; Palmieri A; Zucchetta P; Antunovic L; Bonifazi E; Novelli G; Trevisan CP; Ermani M; Manara R; Angelini C
J Neurol; 2010 Aug; 257(8):1246-55. PubMed ID: 20221771
[TBL] [Abstract][Full Text] [Related]
4. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
[TBL] [Abstract][Full Text] [Related]
5. Molecular Diagnosis of Myotonic Dystrophy.
Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
[TBL] [Abstract][Full Text] [Related]
6. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
[TBL] [Abstract][Full Text] [Related]
7. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
9. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
10. Executive Dysfunction, Social Cognition Impairment, and Gray Matter Pathology in Myotonic Dystrophy Type 2: A Pilot Study.
Theodosiou T; Christidi F; Xirou S; Karavasilis E; Bede P; Papadopoulos C; Argyropoulos GD; Kourtesis P; Pantolewn V; Ferentinos P; Kararizou E; Velonakis G; Zalonis I; Papadimas G
Cogn Behav Neurol; 2022 Sep; 35(3):204-211. PubMed ID: 35867610
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
12. Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.
Gliem C; Minnerop M; Roeske S; Gärtner H; Schoene-Bake JC; Adler S; Witt JA; Hoffstaedter F; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Amunts K; Klockgether T; Weber B; Kornblum C
PLoS One; 2019; 14(3):e0213381. PubMed ID: 30845252
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.
Wei C; Stock L; Schneider-Gold C; Sommer C; Timchenko NA; Timchenko L
Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29735719
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
16. Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2.
Rossi S; Romano A; Modoni A; Perna F; Rizzo V; Santoro M; Monforte M; Pieroni M; Luigetti M; Pomponi MG; Silvestri G
Eur Neurol; 2018; 79(3-4):166-170. PubMed ID: 29533949
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.
Theodosiou T; Christidi F; Xirou S; Bede P; Karavasilis E; Papadopoulos C; Kourtesis P; Pantoleon V; Kararizou E; Papadimas G; Zalonis I
Cogn Behav Neurol; 2021 Mar; 34(1):1-10. PubMed ID: 33652465
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
20. [Myotonic dystrophy - a new insight into a well-known disease].
Lusakowska A; Sułek-Piatkowska A
Neurol Neurochir Pol; 2010; 44(3):264-76. PubMed ID: 20625963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
